Can You Smoke Weed While Taking Bupropion?

Smoking weed while taking bupropion is not strictly prohibited, but the combination carries real pharmacological risks that most people are unaware of. Cannabis directly interferes with the liver enzyme responsible for breaking down bupropion, which can raise bupropion levels in your blood and intensify side effects like irritability, insomnia, and restlessness. Beyond that enzyme interaction, the two drugs overlap in ways that affect your heart, your seizure threshold, and your mental state in sometimes contradictory directions. The picture is more nuanced than a simple yes or no, and the details matter.

How Cannabis Interferes with Bupropion Metabolism

Bupropion is almost entirely broken down by a single liver enzyme called CYP2B6. When you smoke cannabis, THC and its metabolites act as inhibitors of that same enzyme. Lab research has shown that two THC metabolites in particular are strong, competitive inhibitors of CYP2B6’s ability to process bupropion.¹ In plain terms, the cannabis metabolites crowd out bupropion at the enzyme’s active site, slowing down how quickly your body clears the drug.

When an enzyme is inhibited this way, the medication it normally processes hangs around longer and at higher concentrations. For a drug like bupropion, where side effects and seizure risk are dose-dependent, this is not a trivial concern. You could be taking your prescribed dose as directed and still end up with blood levels closer to what you would see at a higher dose, simply because the cannabis is slowing your body’s ability to metabolize it.

This interaction is not theoretical. A clinical study found that participants who actively smoked cannabis while on bupropion experienced increased adverse effects, including irritability, restlessness, and insomnia, compared to what would typically be expected from bupropion alone.¹ Researchers specifically attributed these amplified side effects to the inhibition of CYP2B6 by cannabinoid metabolites.

Side Effects You Should Watch For

If you use cannabis while on bupropion, the side effects most likely to get worse are the ones bupropion already tends to cause on its own. Bupropion is a stimulating antidepressant. Unlike SSRIs, which often cause drowsiness or emotional blunting, bupropion tends to be activating. That means its common side effects lean toward insomnia, agitation, dry mouth, and anxiety. When cannabis slows the clearance of bupropion, those effects can ramp up.

The specific symptoms flagged in the clinical evidence are irritability, restlessness, and trouble sleeping. These overlap with bupropion’s known side-effect profile, but the combination makes them more pronounced. If you are already someone who finds bupropion slightly activating or who has trouble sleeping on it, adding regular cannabis use could push those side effects from tolerable to genuinely disruptive.

The seizure risk also deserves attention. Bupropion carries a dose-dependent risk of seizures, which is one of the reasons prescribers cap the daily dose. If cannabis is effectively raising your functional bupropion levels by blocking its metabolism, that seizure threshold could be lowered even when you are taking the prescribed amount. This risk is hard to quantify precisely because the clinical data on the combination is limited, but the pharmacological mechanism is clear enough that most clinicians would flag it.

The Dopamine Puzzle

Bupropion works primarily by blocking the reuptake of dopamine and norepinephrine, keeping more of these neurotransmitters active in the brain. THC also affects dopamine signaling, though through a different route involving the endocannabinoid system. This overlap creates some unexpected interactions.

Research in primates found that bupropion’s effect on dopamine transport may actually reduce the subjective effects of THC. In other words, the high you get from cannabis might feel blunted or different when you are on bupropion.² This finding has a practical flip side: the same dopamine mechanism that dulls the high from cannabis appears to enhance the discomfort of cannabis withdrawal. If you are a regular user and you stop, bupropion could make the withdrawal period feel worse than it otherwise would.

This is not just a theory. A small inpatient study maintained regular marijuana smokers on either bupropion (300 mg/day) or placebo for several weeks, then switched them from active marijuana to placebo marijuana to simulate withdrawal. During that withdrawal phase, the bupropion group reported significantly more irritability, restlessness, depression, and trouble sleeping compared to the placebo group.³ In essence, bupropion made the withdrawal experience harder, not easier.

Why the Withdrawal Data Is Contradictory

If you search for information on bupropion and cannabis, you may find sources suggesting bupropion actually helps with marijuana withdrawal. That is not wrong either, but the story is messier than it first appears. A separate pilot study in chronic cannabis users found that bupropion-treated participants had lower craving scores and reported fewer withdrawal discomfort symptoms in the week following cessation compared to a placebo group.⁴ Participants on bupropion were also more likely to complete the study, suggesting better retention during cessation efforts.

So how can bupropion both worsen and improve cannabis withdrawal? The answer likely lies in study design and what gets measured. The study showing worsened mood used a controlled inpatient setting where participants were abruptly switched from active cannabis to placebo, and mood was the primary outcome. The study showing benefit measured overall discomfort scores and craving over a longer withdrawal window. It is possible that bupropion worsens certain acute emotional symptoms like irritability and depression during the first days of withdrawal while simultaneously reducing broader withdrawal discomfort and cravings over a longer time horizon. Both findings can be true without contradicting each other, they just describe different windows and different symptoms.

For someone who uses cannabis regularly and is considering whether bupropion could help them quit, this nuance matters. You might experience a rougher emotional transition in the first few days, even as the overall trajectory of craving and discomfort improves over weeks. Knowing this ahead of time can make the difference between sticking with the process and abandoning it because the first few days felt unexpectedly bad.

Psychiatric Risks When the Two Overlap

Both bupropion and cannabis independently carry some risk of triggering psychotic symptoms in vulnerable people. A systematic review of case reports found evidence that bupropion can cause or worsen psychosis in certain populations, with higher doses, preexisting psychotic symptoms, substance abuse, and drug interactions all increasing the likelihood.⁵ Case reports of bupropion-related psychosis have specifically been reported against a background of substance abuse.⁶

Cannabis, particularly high-THC strains, is independently associated with increased risk of psychotic episodes, especially in people with a personal or family history of psychotic disorders. When you combine the two, you are stacking risk factors. The enzyme inhibition discussed earlier compounds this: if cannabis raises your effective bupropion levels, you are getting the psychosis-risk profile of a higher bupropion dose on top of whatever psychosis risk the cannabis itself carries.

For most people without a personal or family history of psychosis, this combination probably will not trigger a full psychotic episode. But if you have any history of psychotic symptoms, mania, or bipolar disorder, the combination of cannabis and bupropion demands extra caution. Bupropion is already prescribed more carefully in people with bipolar disorder because it can trigger manic episodes. Adding cannabis to that equation makes an already delicate situation harder to manage.

Cardiovascular Concerns

This is an area where the risks come less from a direct drug interaction and more from the additive effects of two substances that each stress the cardiovascular system in their own way. Bupropion can raise blood pressure modestly, which is why blood pressure monitoring is standard for people taking it. Cannabis acutely raises systolic blood pressure and can cause orthostatic hypotension, where your blood pressure drops when you stand up.⁷

Cannabis has also been linked to arrhythmias and an increased risk of heart attack, particularly in the first few hours after use.⁷ These cardiovascular effects are compounded by cigarette smoking and triggered by excessive physical activity shortly after consumption. If you are on bupropion and your blood pressure is already running on the high side, adding cannabis could push things into uncomfortable or risky territory. This is especially relevant for people who are using bupropion for smoking cessation and are simultaneously consuming cannabis, since the cardiovascular effects of each substance stack up.

For younger, otherwise healthy people, these cardiovascular risks are generally low in absolute terms. But for anyone with an existing heart condition, hypertension, or a history of arrhythmias, the combination adds meaningful risk that should be discussed with a prescriber.

Does It Matter Whether You Smoke, Vape, or Eat Cannabis?

The route of cannabis consumption changes the interaction profile in ways most people do not consider. The CYP2B6 inhibition caused by THC metabolites occurs regardless of how you consume cannabis, because it happens in the liver after THC is absorbed and processed. Whether you smoke a joint, hit a vape, or eat an edible, the same metabolites end up circulating through your liver and interfering with bupropion metabolism.

However, smoking cannabis introduces an additional variable: the combustion byproducts. Smoke from any plant material, including cannabis, contains polycyclic aromatic hydrocarbons that can induce certain other liver enzymes. This is the same mechanism by which tobacco smoking affects drug metabolism. In practice, smoked cannabis delivers a faster and more variable THC dose than edibles, which means the timing and intensity of the enzyme inhibition is less predictable. Edibles, by contrast, produce a slower but more sustained wave of THC metabolites through the liver, potentially creating a longer window of enzyme inhibition.

Neither route eliminates the interaction. If anything, edibles might produce a more prolonged interference with bupropion metabolism because of their slower absorption and extended metabolite production. The common assumption that edibles are “safer” because they avoid lung exposure is true for respiratory health but does not extend to drug interactions that happen in the liver.

Frequency and Dose Both Matter

An occasional puff at a social gathering and daily heavy cannabis use are not the same conversation when it comes to bupropion interactions. The degree of CYP2B6 inhibition depends on how much cannabinoid metabolite is circulating in your system. A single, light exposure probably produces a brief and modest bump in bupropion levels. Daily or near-daily cannabis use, on the other hand, means your liver is constantly dealing with a stream of CYP2B6 inhibitors, creating a sustained elevation of bupropion blood levels.

This distinction matters for side effects. Someone who uses cannabis once or twice a month while taking bupropion might notice slightly worse insomnia on the night they use it, or a bit more jitteriness the following day. A daily user could be living with chronically elevated bupropion levels without realizing it, attributing the resulting irritability, insomnia, or anxiety to the bupropion itself rather than to the interaction. If you have been on a stable dose of bupropion and your side effects seem to have gotten worse since you started using cannabis more regularly, the enzyme interaction is a likely explanation.

The potency of the cannabis also plays a role. Modern cannabis products, particularly concentrates and high-THC flower, deliver far more THC per use than what was typical even a decade ago. More THC means more of the metabolites that inhibit CYP2B6, which means a stronger interaction. Low-THC, high-CBD products may produce less enzyme inhibition from the THC side, though CBD has its own set of enzyme interactions that complicate the picture in different ways.

When Bupropion Is Prescribed for Cannabis Cessation

There is a specific clinical scenario worth addressing: some people are prescribed bupropion specifically to help them stop using cannabis. Bupropion is well-established as a smoking cessation aid for tobacco, and researchers have explored whether it could serve a similar role for cannabis. The evidence, as described earlier, is mixed but cautiously promising for certain aspects of withdrawal.

The pilot study data showed that bupropion-treated participants had significantly lower craving ratings during the withdrawal period and that their overall discomfort scores did not spike the way the placebo group’s did.⁴ Completion rates were also modestly higher, with half of the bupropion group finishing the study compared to a third of the placebo group. These are small numbers from a pilot study, not definitive evidence, but they suggest bupropion may have a role in helping people stick with a quit attempt.

If you are in this situation, the practical takeaway is that the transition period, when you are still using some cannabis but tapering down while on bupropion, is the window where side effects are most likely to be amplified. Once you have fully stopped, the enzyme inhibition fades as THC metabolites clear your system (which can take weeks for heavy users because THC is fat-soluble), and bupropion metabolism should return to normal. During that transition, being aware that irritability and sleep disruption are expected and pharmacologically driven can help you distinguish between “this isn’t working” and “this is the interaction and it will pass.”

What Your Prescriber Probably Will Not Mention

Most prescribers, when writing a bupropion prescription, do not ask about cannabis use or mention the interaction. This is not because the interaction is unimportant. It is because cannabis-drug interactions are poorly covered in standard pharmacy databases and clinical decision support tools. The formal drug interaction literature for cannabis lags far behind what exists for other substances, partly because of cannabis’s regulatory status and partly because the research is fragmented across small studies.

Bupropion prescribing information warns about seizure risk in the context of alcohol and sedative use, but cannabis is not typically singled out. The enzyme interaction is documented in pharmacology research, but it has not yet been formalized into the standard interaction warnings that pop up in electronic prescribing systems. This means the onus falls on you to bring it up. If you are using cannabis regularly and are prescribed bupropion, mentioning it to your prescriber lets them factor it into dosing decisions and side-effect monitoring. They may choose a lower starting dose, schedule more frequent check-ins, or simply set expectations about what to watch for.

Adolescents and Young Adults

Bupropion is sometimes used in adolescents, particularly those with ADHD and co-occurring mood or substance use disorders. A study of adolescent outpatients with ADHD, mood disorders, and substance abuse found that bupropion treatment was associated with significant reductions in ADHD symptoms, depression scores, and substance use severity over six months, without significant adverse events.⁸ That is encouraging, but it also means there is a population of young people on bupropion who are particularly likely to be exposed to cannabis.

Adolescents and young adults face additional considerations. The adolescent brain is still developing, and both cannabis and bupropion interact with dopamine systems that are undergoing significant maturation during this period. The psychosis risk from cannabis is highest in adolescence and early adulthood, and bupropion’s own capacity to unmask psychotic symptoms in vulnerable individuals compounds that concern. For young people on bupropion who are also using cannabis, the combination warrants closer monitoring than it would in a middle-aged adult with no psychiatric history beyond depression.